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Cerebrovascular disease is an exciting subject, so
complex that we could devote 30 minutes to a discussion of aspirin, dipyridamole, and sulfinpyrazone and their potential actions in the prevention of
thromboembolic events. A Classification and Outline
of Cerebrovascular Disease II , published in the Septem her-October 1975 issue of Stroke, depicts this
complexity. The portion labeled "outline" describes
some of the things summarized in this paper.
The first part of the Classification is labeled
"Clinical Stage"; it is where we make contact with
most patients, including even those with asymptomatic bruit. The "Clinical Stage" is subdivided into
"Transient lschemic Attacks," "Progressing Stroke,"
and "Completed Stroke." TIA is the abbreviation for
transient focal cerebral ischemic attacks. It has become popular. in the United Kingdom to refer to
syncope as a TIA; elsewhere in the world, however,
the word "focal" must be included in the term transient cerebral ischeniic attack; thus syncope is not
listed urider "Transient lschemic Attacks." TI As are
important because they are warnings of a serious or
progressing or devastating stroke to come . They have
certain significant characteristics: the onset is rapid
(defined as no symptoms to maximal symptoms in
less than two minutes) ; the duration commonly is 2
to 30 minutes. In an attempt to establish a standard,
we state in the Stroke dassification that a TIA can
last as long as 24 hours . Seldom ; however, does a TIA
last 24 hours ; most of us believe that someone who
has a focal cerebrovascular event which lasts 20
hours probably has a small infarct. An attack which
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lasts two to five or ten minutes, as in amaurosis
fugax, has not in that instance produced retinal ischemia to the point of retinal infarction. The same
theory applies to the brain; an attack of short duration does not produce cerebral infarction. The resolution or disappearance of each episode is swift; the
frequency of attacks is variable. Significantly, the
diagnosis is almost always made on the basis of the
history , particularly in office practice. Over 25 years I
have witnessed only a few attacks. Frequently I am
asked, "Did you really complete the study and prove
the diagnosis by doing an arteriogram?" An arteriogram will not reveal whether a patient has had a
TIA or not; it will only display detail concerning the
morphology of the vessels. Anatomically, TIAs are
subdivided into two categories; carotid and vertebrobasilar. With the development of surgical reconstruction for lesions in the carotid system, there is every
reason for making the clinical distinction between
these two symptoms.
The typical history for a TIA in the carotid [arterial]
system is ... :
I . Motor defect (weakness, paralysis, poor use, or
clumsiness of one extremity or of both extremities on the
same side).
2. Sensory defect (numbness including loss of sensat ion or paresthesias involving one or both exremities
on the same side).
3. Aphasia (speech and/or language disturbance
which may be only a minor defect or may be global and
may or may not include difficulty in reading , writing, or
performing calculations).
4. Loss of vision in one eye or in part of one eye
when vision in both eyes was intact (amaurosis fugax).
5. Homonymous hemianopia.
6. Combinations of th e above.
These clinical phenomena generally represent a decrease or absence of function. When th ere is a sensory
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event, it is commonly described as coming on all a t once,
that is , without a march .
The typical history for a TIA in the vertebrobasilar
arterial system is ..
I . Motor defect (weakness, clumsiness, or paralysis
of any combination of extremities up to quadriplegia,
sometimes changing from one side to another in different attacks).
2. Sensory defect (numbness, including loss of sen sation or paresthesias in any combination of extremities
including all four or involving both sides of the face or
mouth. This is frequently bilateral trouble or the distribution may change from side to side in different attacks).
3. Loss of vision, complete or partial in both homonymous fields (bilateral homonymous hemianopia) .
4. Homonymoµs hemianopia.
5. Ataxia, imbalance, unsteadiness, or dysequilibrium
not associated witli vertigo.
6. Either vertigo (with or without nausea and vomiting), diplopia, dysphagia , or dysarthria is not to be considered as a TIA when any of these symptoms occurs
alone, but in combination with one another or with any
of the above (numb6rs I, 2, 3 and 4) the attacks should be
considered a TIA.
7. Combinations of the above.
These clinical phenomena generally represent a decrease or absence of function. At times, the motor, sensory , or visual defect constituting the content of a vertebrobasilar attack will be unilateral. It becomes difficult
in such instances to make a distinction between whether
the locu s of ischemia is in the carotid arterial system or in
the vertebrobasilar arterial system . In the list above,
"drop attacks" is omitted. Fainting (syncope) is frequently confused with a " drop attack, " so the latter
shou ld be included in the vertebrobasilar profile only
when the patient's description of the "drop attack " is
absolutely clear. The variety of manifestations included
in the vertebrobasilar profile makes the potential pattern of symptoms considerably more variable and complex than that in the carotid system.
The diagnosis of TIA rests on the history of the attacks; the skill with which the history is taken and the
interpretation of the history , except for those relatively
few instances where the physician is with the patient at
the time of the attack. The criteria for making the diagnosis will vary depending on whether an individual
physician is working with an individual patient or
whether the purpose is the screening of a population for
TIAs. A problem is created, as in much of medical diagnosis , because of the relative weight or significance of
some historical phoriomena compared to other phenomena. The symptom "numbness" (mentioned above) is
an example . If the question is, "Have you ever had a
numb hand 0 , " the answer from most adults will be "yes."
This question is almost completely non-selective (nondiagnostic) and must be followed by a series of questions
to estab lish the meaning and significance of the "numbness. " In contrast , another phenomenon , when present ,
is simp le and relatively much more significant than
"numbness;" i.e. , "Have you ever had painless blindness
in one eye which cam e on very quickly (seconds) and

lasted only a few minutes (5 to 20)?" is a question
which , if answered "yes," is reasonably specific. Another
similar but less specific question is " Have you ever had
the sudden onset of a 5 to 20-minute duration attack of
severe weakness of one side of the body (arm and leg)?"
Another is "Have you ever suddenly lost the ability to
speak (5 to 20 minutes' duration) or to understand the
speech of others?" These questions illustrate the importance of understanding that different questions may have
relatively different cqmplexity and importance.
The matter of relative significance of different sym toms is important in the vertebrobasilar system as it is in
the carotid system. For instance, if one asks the question ,
"Have you ever had any dizziness" ," almost all adults
will answer "yes." This question is almost completely
non-selective (non-diagnostic) and if answered affirmatively must be followed by a series of direct and branching questions to e?tablish the meaning and signific;mce
of the original phenomenon-"dizziness." A diagnosis of
a TIA in the vert~brobas il ar system should not be made
on the basis of a history of a few minµtes of vertigo as the
on ly symptom. This is emphasized since vertigo is the
most common symptom in the vertebrobasilar system ;
ho wever, a diagnosis of vertebrobasilar TIA is made only
when there is concurrently with vertigo (dizziness) an additional symptom or symptoms.
In some instances, patients with carotid system
TIAs may ha ve physical signs of appropriate arterial
disease. These include diminished pulsation in the carotid
artery , a bruit over the carotid artery or eye, embo li in
the retinal vessels, or other signs of ischemic retinopathy
and relative hypotension in the retinal artery as meas ured
with the ophthalmodynamometer. These are only signs
of arterial disease and may be present in the absence of
a history of TIAs. In certain instances , bruits signifying
compromise of flow in the innominate artery, either
subclavian artery, or at the origin of ei ther ve rtebral
artery may be present ; however, th e a bsence or presence
of such sounds does not weigh heavily in the diagnosis of
vertebrobasilar TIA since it is again emphasized that
the diagnosis is dependent upon the history of the attack , not upqn morphological evidence of change in
patterns of blood flow .
Certain symptoms may appear in a TIA in either
arterial system. The most important of these are:
I. Dysarthri~ , if it occurs alone, and
2. Homonymous hemianopia , if it occurs alone.
The occurrence of certain symptoms in solitary
fashion constitutes an attack which is an "uncertain
TIA. " An attack which cons ists so lel y of each of the following symptoms should be categorized as an unce rtain
TIA:
I . Vertigo a lone
2 . Dysarthria a lon e
3. Dysphagia alone
4. Diplopia alone
For the sake 9f clarity, the following symptoms ,
transient or prolonged, are not to be included as TIA:
I. Unconsciousness including syncope
2. Tonic and / or clonic activity
3. March of a sensory defect
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4. Vertigo alone
5. D ysphagia alone
6. D ysarthria alone
7. Incontinence of bowel or bladder
8. Dizziness or wooziness a lone
9. Loss of vision associated wi th alteration of consciousness
10. Focal symptom s associated with migraine
11. Scintillating scotomata
12. Confusion alone
13. Amnesia alone
The different ial diagnosis of TIAs includes "hemiplegic" migraine, focal convulsive events (often due to
neoplasm and producing either sensory or motor
phenomena), Meniere' s disorder, sensory phenomena
associated with hyperventilation, and finally some unknown mechanism. The differentiation of "hemiplegic"
migraine is a semantic a nd practical problem. In those instances where the aura of migraine is associated with a
definitely focal neurological event, the latter may well
be the result of transient focal cerebral ischemia but the
implications are different than the usual TIA. To establish a diagnosis of the migraine association, there
is ordinarily a positive family history, characteristic unilateral headache with nausea and sometimes vomiting,
and onset of the attacks several deca des ahe~d of the age
at which T!As commonly begin. Very careful historytaking ordinarily delineates the transient focal events
associated with brain neoplasm from T!As and this is
also true of the other items in the differential diagnosis.'

It is necessary to understand the pathogenesis of
the attacks to treat them properly. Strokes occur in
people who have atherosclerosis; common sites are in
the cervical arteries and in the circle of Willis and its
main branches. Strokes do not occur in patients free
of atherosclerosis unless there is a distal occlusion by
an embolus from the heart or other site. Cerebral
infarcts are statistically associated with ather()sclerosis. How does a static atherosclerotic lesion
in the neck produce the sudden onset, in a matter of
seconds, of a hemiparesis which lasts for five minutes
and disappears leaving the person normal? How often does cerebral atherosclerosis occur without causing symptoms? In 100 consecutive autopsies of
patients 50 years of age or older, the arch of the
aorta, all cervical vessels, vessels at the base of the
brain , and the brain were studied. Under the term
"stenosis," only a lumen narrowed 50% or more was
counted. There were 77 cervical stenoses in 28
patients. Of these 28 people, 18 had never had any
symptoms of nervous system trouble of any kind .
There were 15 cervical occlusions in 12 people. Six of
these 12 had never had any symptoms of nervo us
system trouble. There were 40 people (40%) of
the I 00 who had cervical atherosclerosis, not count-

ing intracranial lesions . Sixty percent of these patients were without any symptoms of nervous system trouble. This same observation has been made
concerning coronary atherosclerosis. Many people
with coronary atherosclerosis have neither angina
nor a myocardial infarction . It is apparent that some
factor, in addition to atherosclerosis, has to be present
to produce the sudden onset and short duration of
the attacks . In 1955, I postulated that atherosclerosis plus one or more of the following could cause
an attack: tra,nsient systemic hypotension, polycythemia, kinking or external compression, shunting,
transient hypoglycemia, vasospasm , severe anemia,
thrombosis or embolism or both. The transient systemic hypotension theory was in vogue over a decade
ago. The notion was that if there were distal stenosis
of an artery and the perfusion pressure dropped ,
there would be a disproportionate decrease in perfusion distal to the stenosis, thereby causing ischemia
for the duration of that decreased perfusion pressure,
and ischemia in the territory supplied by that vessel.
The physician should search for cardiac causes of
transient systemic hypotension even though this is an
uncommon cause of TIA. At the Mayo Clinic, only
1.4% of 290 consecutive patients being implanted
with cardiac pace makers had had focal transient neurological phenomena. In most instances there were
episodes of diffuse cerebral ischemia (syncope). Polycythemia is found in I% or 2% of our TIA patients,
whether vertebra-basilar or carotid. Polycythemia
should be appropriately studied and treated . Reversal
of flow in a vertebral artery because of occlusion or
stenosis of a subclavian artery has been called "subclavian steal." It can be diag nosed in the office as
there is a decrease in brachial blood pressure on the
side involved, a radial pulse lag, and a decrease in the
palpable pulse pressure on that side. The symptom
complex associated with this, certainly in our institution, has never been defined and operations for this
defect are seldom performed .
The items of greatest importance in the pathogenesis of TIA appear to be thrombosis and embolism . Cholesterol and fibrin-platelet emboli have been
observed in the retina; streamlining of flow explains
the similarities between the neurological content of a
patient's attacks while fragmentation of emboli or
lysis of thrombosis is a plausible explanation for the
short duration of episodes. The appearance of cholesterol emboli in the retina means that there is an
ulcerated carotid lesion on that side.
The natural history of TIA has received consid-
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erable study. Are TIAs warning events? Twelve reports are summar ized in the following table (Table
I ).

The one study with a result different from the
others is Marshall's. 9 A few months later, Marshall 13
published an entirely different result ; 43 % of TIA
patients had cerebral infarction when followed for
60 months. In Marshall's first report it appears that
many of the patients had a complaint of occasional
dizziness and were not having focal cerebral transient
ischemic attacks. In the study by Pearce et al,5 the
duration of follow-up was only 10.6 months which
is too short a time to discover the true natural history
of TIA .
One is often asked about the indications for cranial arteriography. These are:
I. Differential diagnosis of the brain pathology.
Even with careful attention to all the items listed
under history, general examination, neurological exam ination , neurovascular examination, and ad ditional tests, there still remain about 5% of patients
whose diagnosis is uncertain. Computerized tomography (EMI, ACTA, DELTA scanners, an d others)
is revolutioni zing the differential diagnosis of intracranial lesion s. In a few instances, cervical-cerebral angiography is the best method for distinguishing between vascular occlusive disease , an
intracerebral expanding mass such as hemorrhage ,
abscess or brain tumor, cerebral infarction, and subdural hematoma , as well as demonstrating aneurysms
and arteriovenous malformations.

2. Transient focal ischemic attacks, particu larly
in the carotid system. Cervical-cerebral angiography
should be performed if one or more of these conditions is evident: amaurosis fugax, bruit over the beginning of the internal carotid artery, retinal emboli,
unilateral decrease in retinal artery pressure, or ischemic retinopathy. If none of these is present, the
likelihood of finding a lesion accessib le to the surgeon
is small.
3. Selected instances of vertebra-basilar TIAs.
It may be difficult to make a clinical distinction between the carotid and the vertebra-basilar system. If
the TIAs are characteristic of those coming from the
vertebra-basi lar system, there is little need for extensive angiography .
4. Early progressing stroke or frequent TIAs in
the carotid system with evidence of amaurosis, an
appropriate bruit, retinal emboli, or other conditions.
5. Many patients with subarachnoid hemorrhage and some patients with intracerebral hemorrhage .
A less certain indication for cranial arteriography is a loud, long systo lic or systolic-diastolic
internal carotid artery bruit in patients scheduled for
major general surgery. If there is prolonged hypoten sion or very severe blood loss , the carotid stenosis
may decrease blood supply to a focal region of the
brain to a critical level of ischemia . Recent observations suggest that such patients do not have an increased risk of stroke; therefore, arteriography is not
necessa ry.

Table I
Twelve Reports Summarizing Natural History of TIAs as Warning Events

STUDY
Sieker! et al'
Cooperative'
Fisher'
Pearce et a I'
Baker et al'
Baker et al'
Fri edman et al'
Marshall'
Ziegler and Hassanein"
Goldner* et al"
Whisnant et al 12
Marshall 13

N UMBER OF
PATIENTS

FOLLOW-UP
(Mos.)

160
20
23
20
30
79
23
61
135
140
Ill
198
158

60
20
10.6
40.6
41
27.4
45
36
180 av •1
av?
60
60

NORMAL
83 (52%)

11 (55%)

54 (89%)

CEREBRAL INFARCT
TOTAL
LETHAL

C EREBRA!.
H EMORRI-IAGE

0

7(4%)
0
0

0

I (2%) SAH

51 (32%)
5 (25%)
8(34%)
2( 10%)
7 (23%)
17 (22%)
8 (35%)
I (2%)
22 (16%)

18( 11 %)
I (5%)

43 (38%)
62 (32%)
68 (43%)

27 (24%)

I (2%)

5 (3.7%)

* Goldner, Whisnant and Taylor reported concerning 140 TIA patients followed for 15 years. The table gives occurrence of stroke
in 111 patients.
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Recalling the thrombosis-embolism mechanism,
it is apparent that there are several ways to treat
TIAs; one of these is the administration of an oral
anticoagu lant. Table 2 shows the data in six reports
in which a direct attempt has been m a de to compare
untreated patients su ffering from transient ischemic
attacks with those receiving a nticoagulant drugs.
Anticoagu lants shou ld not be used if: I). the
physician is unfamiliar with the drugs, 2) the patient
is not fully cooperative, or 3) laboratory results are of
uncertain quality. The actual number of patients in
five of the st udies in Table 2 is so sm a ll as to make
comparison between the treated and untreated
groups invalid. Nevertheless, the percentage of ind ividuals with cerebral infarction was similar in
all of the treated groups of each study. The effectiveness of concurrent treatment of arterial hypertension,
in decreasing the frequency of intracerebral hemorrhage, cannot be assessed in these studies; it seems
reasonab le that the danger may be less now that
a ntih ypertensive therapy is better developed. It is
apparent that anticoagulant therapy decreases the
risk of cerebral infarction in patients with transient
ischemic attacks . However, other types of treatment
should be considered including thromboendarterectomy an d the administration of an tiplatelet agg lutinating agents.

Although thousands of operations on the carotid
artery have been performed since the report by Eastcolt, Pickering and Rob 14 in 1954, knowledge concerning the effects of surgery to prevent subseq uent
cerebra l infarction in patients with T IA is still limited. In the Joint Study of Extracranial Arteria l Occl usion V, 15 the collaborating in vestigators reported
that 316 patients had transient ischemic attacks; 169
received surgical treatment and 14 7 received medical
treatment. The follow-up period averaged 42 months.
In the surgically t reated gro up, 15% of the patients
suffered cerebral in farct ion (including postoperative
comp lications) while 14% of the medicall y treated
subjects had cerebral infarction. The best results were
noted in a subgroup of 94 patients having transient
ischemic attacks and unilateral carotid stenosis; 45
underwent surgery and 49 were treated medica lly. Six
percent of the su rgica lly treated patients had cerebral
infarcti o n during the tota l course o f the study compared with 12% of the med icall y treated group. Bauer
et a l, 16 a lso reporting for the Joint Study of Extracranial Arterial Occlusion, noticed statistically significant differences in the cumulative survival rates at 42
months a nd reported that:
(I) surgical treatment appeared more beneficia l for
uni lateral carot id stenosis in patients with transient
ischemic attacks or a mild to moderate neurological

TABLE 2
Six Studies Comparing Untreated TIA Patients with Those Receiving Anticoagulant Therapy
STUDY
Sieker! el al'
Control
Treated
Cooperative Study'
Control
Treated
Fisher'
Con trol
Treated
Pearce et a l'
Control
Treated
Baker et al'
Control
Treated
Friedman et a l'
Contro l
Treated

NUMBER OF
PATIENTS

FOLLOW-UP
(Mos.)

NORMAL

160
175

60
60

83 (52%)
131 (75%)

20
24

20
18

5 (25% )
I (4% )

23
29

30

8(34% )
I (3% )
11 (55% )
7 (4 1% )

CEREBRAL INFARCT
LETHAL
TOTAL
5 1 (32% )
7(4% )

10.6

30
30

40.6
37.9

7* (23%)
2

23
21

27.4
27.4

8•
0

* Three treated patients randomly chosen had CY A after A/ C stopped.
One cerebral hemorrh age in treated group but while off anticoagulant.
' One patient had been on A/ C, but A / C was discontinued before the cerebral infarction.

I

18 ( 11 %)
3(2% )

7 (4% )
13 (7%)

I (5% )
0

0
2 (8% )

0
0

0
0

2 (10% )
I (5% )

20
17

II.I

CE REBRAi.
H EMO RRIIAGF

o,
0
0

I (4%) SAH
0
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deficit, (2) nonsurgical treatment produced better results
for unilateral carotid stenosis in patients with a moderate
to severe neurological deficit, (3) nonsurgical treatment
appeared more beneficial for combined unilateral
protid artery stenosis and contralateral carotid artery
occlusion o f patients who had a moderate to severe
neurological deficit, and (4) nonsurgical treatm ent appeared more beneficial for patients with completed
strokes who had a marked and persistent neurological
deficit.

It is apparent from the many reports in the literature that physicians clinically active in the cerebrovascular field are moderately to greatly enthusiastic
about surgical treatment for carotid system TIA
when an appropriate carotid lesion is discovered. Unfortunately, no long-term follow-up of a precisely
studied group of surgically treated carotid TIA
patients is available, but it seems likely that results
have improved since the report by the Joint Study of
Extracranial Arterial Occlusion .
In the last decade, aspirin, dipyridamole (Persantine®) and sulfinpyrazone (Anturane®) have been
investigated in the laboratory and in some human
clinical settings because of their effect on blood platelet aggregability or adhesiveness or both. A direct
relationship between these characteristics of platelets
a nd the pathogenesis of transient ischemic attac ks
has not yet been firmly established. Dyken et a l1 7 described 26 patients, in a retrospective study, of whom
15 were treated with aspirin (300 mg b.i .d.) and 11
were not. No difference was noted in the incidence of
cerebral infarction or death in the two groups, but
only two ( 13%) of those receiving aspirin had an additional TIA while nine (82%) of those receiving no
aspirin had subsequent TIA . The author stressed that
this study did not prove the effectiveness of aspirin,
but that it pointed to the need for a prospective investigation of the subject.
Two cooperative studies of platelet aggregating
agents' effect on transient ischemic attacks are underway, one in Canada and one in the United States.
Formal com prehensive reports from these studies are
not yet available. Atthe Tenth Princeton Conference
on Cerebral Vascular Disease in 1976, Fields 18 gave a
brief overview of some of the experience in the
United States Cooperative Study of aspirin for the
treatment of transient focal cerebral ischemic attacks.
He reported that in patients hav ing one attack, there
was no difference between treated and untreated
patients, but that in p atients having multiple TIAs,
those receiving aspirin appeared to have a better "result." This Cooperative Study has been discontinued.
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Barnett'" (Canadian Cooperative Study ) was asked
about the results of his investigation which involved
comparisons between several treatments (aspirin, sulfinpyrazone, and other drugs). He commented that
the statistics to date had been carefully reviewed and
that the results appeared to be inconclusive. There
was no reason to stop the investigation and every
reason to continue it. At this time, the pressing questions concerning the effectiveness of these agents remain unanswered .
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